Here we reported that IL-15 and IL-18 showed similar proliferative promotion in NK cells from CAD patients and healthy subjects, while the other three interleukins did not show statistically significant promotion (Figures 1A, B). This evidence concerns the gene IL18 and coronary artery disorder.